biopharma-reporter41m
Setback for Inhibikase Parkinson’s therapy
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.
'There will be a cure for Parkinson's one day'
So I really depend on my medication." Sir Peter Luff, a former defence minister and MP for Mid Worcestershire, explained how ...
AI model identifies potential risk genes for Parkinson's disease
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Can mold exposure cause Parkinson’s disease? Colorado family hopes to prove 'landmark' legal case
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...
Vail Daily2dOpinion
Haims: Educate yourself about Parkinson’s treatments
Parkinson’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. In the United ...
India Tribune2d
Indian scientists develop nano-formulation to bring safer treatment for Parkinson’s
Scientists from the Institute of Nano Science and Technology (INST) Mohali, an autonomous institute of the Department of ...
devdiscourse3d
Nano Formulation for Sustained Release of 17β-Estradiol Shows Promise in Parkinson's Disease Therapy
In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation ...
sambadenglish3d
Scientists in India develop nano-formulation for safer treatment of Parkinson’s patients
Scientists from the Institute of Nano Science and Technology Mohali announced a targeted nano-formulation that will enable ...